Resource Center

Go back to Resource Center

Prograf as secondary intervention vs continuation of cyclosporine in patients at risk for chronic renal allograft failure (CRAF) results in improved renal function, decreased CV risk, and no increased risk for diabetes

2003

Journal Article

Authors:
Group, theC.R.A.F.Study

Location:
Washington D.C.

Go back to Resource Center